Acne stigma linked to 20% higher depression odds in teens

In 74 adolescents with acne vulgaris, each one-point increase in internalized stigma was associated with 1.20 times the odds of major depressive symptoms (95% CI, 1.08–1.33; p = 0.001), a prospective case–control study found. The association persisted after accounting for sociodemographic and clinical factors, making internalized stigma an independent predictor rather than a simple marker of acne severity.

Researchers included 74 adolescents with acne vulgaris and 80 healthy controls, 154 participants in all. Esra Kiratli Nalbant, Aysun Aydin Firat, Kaan Celebier and Yildiz Hayran published the 2026 study in Archives of Dermatological Research, volume 318, issue 1, article 543; its DOI is 10.1007/s00403-026-05020-9.

The paper, “Internalized stigma as an independent predictor of depression in adolescents with acne vulgaris: a prospective case–control study,” examined sociodemographic and clinical influences on depression and anxiety. The authors also asked whether internalized stigma represented an independent psychopathological mechanism.

Every participant completed a sociodemographic form and the Revised Children’s Anxiety and Depression Scale (RCADS). Its subscales assess social phobia, generalized anxiety disorder and major depressive disorder. Adolescents with acne additionally completed the Acne Internalized Stigma Scale (AISS) and the Children’s Dermatology Life Quality Index (CDLQI). The report did not provide a separate numerical estimate for CDLQI.

What did the acne and control groups show?

Significantly more adolescents with acne scored above validated cutoffs for social phobia and the RCADS major depressive disorder subscale than healthy controls. No significant between-group difference emerged for the generalized anxiety disorder subscale. The authors interpreted this pattern as a psychological burden concentrated in depressive symptoms and social fears, rather than pervasive worry. Their findings therefore supported two of the study’s three RCADS comparisons, while leaving no significant group difference on generalized anxiety.

How strong was the stigma-depression association?

Within the acne group, regression analysis identified internalized stigma as an independent predictor of depression. Each one-point AISS increase corresponded to an odds ratio of 1.20 for the major depressive disorder outcome, with a 95% confidence interval of 1.08–1.33 and p = 0.001. In practical terms, the score linked to 20% higher odds of the depression outcome per point. It did not mean 20 percentage points more adolescents developed depression, because the analysis reported an odds ratio rather than a change in prevalence. Kiratli Nalbant and colleagues concluded that internalized stigma “predicts depression irrespective of sociodemographic or clinical factors.”

Does the study establish that stigma causes depression?

The study does not establish causation. The 154-participant case–control comparison supports associations and statistical prediction within the studied groups, not proof that stigma causes depression over time. The abstract reports odds ratios rather than long-term outcomes, and the authors proposed psychological screening rather than testing a screening or counseling intervention.

The RCADS findings concern symptom thresholds, not a longitudinal diagnosis, because the report provides odds ratios rather than long-term outcomes. The finding therefore identifies internalized stigma as a specific risk marker within this acne cohort, not a proven causal pathway. The authors still consider the independent-predictor result clinically meaningful because it points to a psychological process that acne severity alone does not capture.

What could change in dermatologic practice?

The authors suggest that stigma awareness and brief psychological screening may “enhance holistic care and improve patient outcomes.” Acne vulgaris is among the most common conditions of adolescence, and affected adolescents frequently report depression and anxiety. They therefore frame acne management as a task that includes psychological care, not only skin symptoms. Adolescence already brings rapid physical and psychological change, while the psychopathological mechanism behind acne-related depression has remained unclear. Isolating internalized stigma offers clinicians a specific target for assessment and gives researchers a testable pathway beyond acne severity and demographic background. Larger longitudinal studies should test whether stigma-focused care and brief psychological screening improve outcomes in dermatology practice. Until then, the 1.20 odds ratio identifies a meaningful association, not a causal effect or a ready-made treatment protocol.